×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by George Eric Davis

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMar 14, 2025Tax Payment (Shares)$69.4416,2491,128,33169,975Mar 18, 2025, 07:51 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 28, 2024Sale$74.5140,8503,043,80258,936May 30, 2024, 06:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 28, 2024Option/RSU Exercise$63.1040,8502,577,63597,007May 30, 2024, 06:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerApr 30, 2024Award/Grant$68.6530120,66256,157May 06, 2024, 04:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 02, 2024Option/RSU Exercise$63.101,850116,73558,007May 06, 2024, 04:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 02, 2024Sale$85.011,850157,26956,157May 06, 2024, 04:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMar 28, 2024Sale$88.3424,6022,173,34155,856Apr 01, 2024, 04:54 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMar 15, 2024Tax Payment (Shares)$83.8721,6991,819,89580,458Mar 19, 2024, 08:53 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerDec 13, 2023Sale$95.3013,7641,311,70955,710Dec 14, 2023, 06:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerAug 08, 2023Sale$89.4211,000983,66269,474Aug 09, 2023, 07:08 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerApr 28, 2023Award/Grant$66.8831721,20180,684May 18, 2023, 05:19 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 16, 2023Gift-210-80,474May 18, 2023, 05:19 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMar 15, 2023Tax Payment (Shares)$87.743,025265,413100,324Mar 17, 2023, 09:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMar 16, 2023Tax Payment (Shares)$93.4119,9571,864,18380,367Mar 17, 2023, 09:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerFeb 24, 2023Option/RSU Exercise$67.811,47499,95256,725Feb 28, 2023, 09:22 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerAug 09, 2022Option/RSU Exercise$67.8147,5263,222,738102,777Aug 11, 2022, 09:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerAug 09, 2022Sale$95.9651,2164,914,66455,251Aug 11, 2022, 09:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerJul 08, 2022Sale$90.007,398665,82058,941Jul 11, 2022, 07:46 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerApr 29, 2022Award/Grant$62.4134121,28166,339May 04, 2022, 12:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 02, 2022Option/RSU Exercise$37.4615,347574,89981,686May 04, 2022, 12:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerMay 02, 2022Sale$80.3815,3471,233,59266,339May 04, 2022, 12:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, Chief Legal OfficerApr 25, 2022Option/RSU Exercise$37.462,66999,98165,998Apr 27, 2022, 08:40 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 21, 2022Sale$81.296,129498,22663,329Mar 23, 2022, 09:16 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 15, 2022Tax Payment (Shares)$78.278,290648,85870,710Mar 17, 2022, 09:24 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 16, 2022Tax Payment (Shares)$80.721,252101,06169,458Mar 17, 2022, 09:24 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselAug 02, 2021Sale$76.695,518423,17558,590Aug 04, 2021, 04:59 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 22, 2021Tax Payment (Shares)$78.521,391109,22168,440Mar 23, 2021, 09:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 16, 2021Tax Payment (Shares)$77.211,25296,66769,831Mar 17, 2021, 09:35 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 15, 2021Tax Payment (Shares)$78.395,014393,04771,083Mar 17, 2021, 09:35 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselApr 30, 2020Award/Grant$62.5933921,21778,181May 04, 2020, 09:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 01, 2020Sale$89.3812,5041,117,60765,677May 04, 2020, 09:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 20, 2020Tax Payment (Shares)$73.053,309241,72277,842Mar 24, 2020, 08:53 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 13, 2020Tax Payment (Shares)$84.507,244612,11871,051Mar 17, 2020, 09:19 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselNov 26, 2019Sale$79.663,190254,11568,709Nov 27, 2019, 06:47 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselApr 30, 2019Award/Grant$68.7830921,25472,199Jun 07, 2019, 07:14 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 05, 2019Gift-300-71,899Jun 07, 2019, 07:14 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 22, 2019Tax Payment (Shares)$88.053,309291,35775,253Mar 26, 2019, 08:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 25, 2019Sale$87.863,363295,47371,890Mar 26, 2019, 08:01 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 19, 2019Sale$93.927,907742,62578,562Mar 21, 2019, 05:00 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 15, 2019Tax Payment (Shares)$94.536,648628,43577,099Mar 19, 2019, 07:39 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 01, 2019Tax Payment (Shares)$94.7684079,59883,747Mar 05, 2019, 07:47 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselSep 14, 2018Sale$99.452,216220,38673,550Sep 18, 2018, 04:42 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselSep 13, 2018Sale$99.5712,0001,194,84074,950Sep 17, 2018, 06:57 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 04, 2018Tax Payment (Shares)$92.071,414130,18786,950Jun 06, 2018, 08:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselApr 30, 2018Award/Grant$68.7830921,25488,364Jun 06, 2018, 08:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 22, 2018Tax Payment (Shares)$81.363,308269,13991,326Apr 27, 2018, 07:11 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 23, 2018Sale$81.353,350272,52287,989Mar 27, 2018, 06:17 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 22, 2018Tax Payment (Shares)$81.363,295268,08191,339Mar 26, 2018, 07:50 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 16, 2018Sale$83.883,818320,25494,634Mar 20, 2018, 07:36 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 15, 2018Tax Payment (Shares)$83.573,757313,97286,332Mar 19, 2018, 09:51 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 05, 2018Sale$79.042,105166,37990,089Mar 07, 2018, 06:06 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 02, 2018Tax Payment (Shares)$79.862,071165,39092,194Mar 06, 2018, 08:39 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselFeb 01, 2018Option/RSU Exercise$38.5930,0001,157,700112,942Feb 05, 2018, 08:13 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselFeb 01, 2018Sale$90.6630,0002,719,66582,942Feb 05, 2018, 08:13 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselNov 30, 2017Sale$85.641,200102,76782,942Dec 04, 2017, 08:26 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 23, 2017Option/RSU Exercise$38.599,844379,88093,425Jun 27, 2017, 08:46 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 23, 2017Sale$96.609,844950,93083,581Jun 27, 2017, 08:46 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 09, 2017Option/RSU Exercise$23.549,239217,53083,581Jun 13, 2017, 08:56 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 05, 2017Sale$91.049,471862,23074,342Jun 07, 2017, 08:26 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 02, 2017Tax Payment (Shares)$90.721,488134,99183,813Jun 06, 2017, 08:39 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 15, 2017Tax Payment (Shares)$91.501,096100,28484,155May 17, 2017, 06:55 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 16, 2017Option/RSU Exercise$14.391,14616,49185,301May 17, 2017, 06:55 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselApr 28, 2017Award/Grant$70.3030221,23285,251May 09, 2017, 01:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 05, 2017Option/RSU Exercise$38.592,50096,47587,751May 09, 2017, 01:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 05, 2017Sale$100.342,500250,85385,251May 09, 2017, 01:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 15, 2017Tax Payment (Shares)$92.502,995277,03875,967Mar 17, 2017, 06:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 16, 2017Sale$91.962,238205,80673,729Mar 17, 2017, 06:31 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 06, 2017Sale$93.321,498139,79378,962Mar 08, 2017, 07:24 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 03, 2017Tax Payment (Shares)$93.951,596149,94480,460Mar 07, 2017, 06:40 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselNov 18, 2016Sale$90.425,000452,10070,798Nov 22, 2016, 07:13 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselOct 07, 2016Gift-360-70,798Nov 22, 2016, 07:13 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselNov 18, 2016Option/RSU Exercise$38.595,000192,95075,798Nov 22, 2016, 07:13 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselAug 01, 2016Sale$100.002,167216,70071,158Aug 03, 2016, 10:13 AM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJul 14, 2016Option/RSU Exercise$38.592,656102,49573,325Jul 18, 2016, 06:02 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 16, 2016Gift-120-72,836Jul 11, 2016, 04:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJul 07, 2016Sale$90.002,167195,03070,669Jul 11, 2016, 04:45 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselJun 03, 2016Tax Payment (Shares)$90.001,488133,92072,956Jun 07, 2016, 11:02 AM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 13, 2016Tax Payment (Shares)$82.711,09690,65074,444May 17, 2016, 03:09 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 06, 2016Tax Payment (Shares)$80.801,696137,03790,198May 10, 2016, 07:06 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 09, 2016Sale$84.5510,000845,53280,198May 10, 2016, 07:06 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMay 10, 2016Sale$86.324,658402,07975,540May 10, 2016, 07:06 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselApr 29, 2016Award/Grant$51.2641421,22391,894May 10, 2016, 07:06 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 14, 2016Sale$86.211,996172,07976,190Mar 16, 2016, 12:39 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselMar 03, 2016Tax Payment (Shares)$89.572,180195,26378,186Mar 07, 2016, 08:43 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisEVP, General CounselFeb 29, 2016Tax Payment (Shares)$81.8717,6561,445,49780,366Mar 02, 2016, 08:35 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselDec 16, 2015Sale$100.001,362136,20066,156Dec 17, 2015, 02:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJun 04, 2015Tax Payment (Shares)$120.461,488179,24467,738Jun 08, 2015, 06:04 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselJun 08, 2015Gift-120-67,618Jun 08, 2015, 06:04 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 18, 2015Sale$125.262,558320,41569,226May 19, 2015, 07:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 15, 2015Tax Payment (Shares)$122.781,096134,56771,784May 19, 2015, 07:18 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselApr 30, 2015Award/Grant$51.2673037,42274,576May 12, 2015, 07:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMay 08, 2015Tax Payment (Shares)$121.661,696206,33572,880May 12, 2015, 07:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 13, 2015Option/RSU Exercise$37.0815,000556,23988,846Mar 17, 2015, 06:03 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 13, 2015Sale$120.8715,0001,813,00573,846Mar 17, 2015, 06:03 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 02, 2015Option/RSU Exercise$26.4923,000609,27087,246Mar 04, 2015, 07:41 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselMar 02, 2015Sale$108.3123,0002,491,01564,246Mar 04, 2015, 07:41 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 25, 2014Option/RSU Exercise$26.4920,000529,80084,426Nov 28, 2014, 09:26 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselNov 25, 2014Sale$89.7520,0001,795,00064,426Nov 28, 2014, 09:26 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselOct 30, 2014Sale$83.2015,0001,247,92964,426Nov 03, 2014, 07:21 PM
BMRNBIOMARIN PHARMACEUTICAL INCGeorge Eric DavisSVP, General CounselOct 30, 2014Option/RSU Exercise$26.4915,000397,35079,426Nov 03, 2014, 07:21 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe